India's dengue vaccine enters final trials, offering hope for affordable, single-dose solutions to combat the global epidemic ...
The team calculated that the mosquitos likely developed their “ anthropophily ”—their taste for human blood—at a point some 2 ...
As dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world's first single-dose shots.
Dengue infects up to 400 million people and kills thousands every year but an Indian company is now inching closer to a ...
20hon MSNOpinion
Climate crisis and health, and AI at the intersection
Disaster management should not wait for a disaster to strike. It should start well in advance through proactive planning, ...
India’s Panacea Biotec begins Phase III trials of its single-dose dengue vaccine candidate DengiAll, offering hope amid ...
Saudi Arabia’s General Entertainment Authority has signed a joint production agreement with MBC Egypt to deliver high-quality media content for the Egyptian audience. The signing took place in Cairo ...
Inquirer.net on MSN
Doctors’ goal: Zero dengue deaths by year 2030
Physicians reaffirmed on Thursday their commitment to combat the disease and have no dengue-related deaths by 2030, as they ...
Mosquitoes are the deadliest animal on the planet, killing hundreds of thousands of people every year by transmitting malaria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results